Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclosporine in ocular surface inflammation.

Literature DB >> 28211880

Cyclosporine in ocular surface inflammation.

P Hossain^1,2.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28211880 PMCID： PMC5437339 DOI： 10.1038/eye.2017.5

Source DB: PubMed Journal: Eye (Lond) ISSN： 0950-222X Impact factor: 3.775

× No keyword cloud information.

16 in total

1. Blepharitis: remains a diagnostic enigma. A role for tea tree oil shampoo?

Authors: P Hossain; A Konstantopoulos
Journal: Eye (Lond) Date: 2015-08-21 Impact factor: 3.775

Review 2. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007).

Authors:
Journal: Ocul Surf Date: 2007-04 Impact factor: 5.033

3. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine.

Authors: B Iaccheri; G Torroni; C Cagini; T Fiore; A Cerquaglia; M Lupidi; S Cillino; H S Dua
Journal: Eye (Lond) Date: 2017-02-03 Impact factor: 3.775

4. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.

Authors: Bennie H Jeng; Douglas S Holsclaw
Journal: Cornea Date: 2011-09 Impact factor: 2.651

5. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.

Authors: Mark R Wilkins; Sharmina Khan; Catey Bunce; Anthony Khawaja; Dilani Siriwardena; Daniel F P Larkin
Journal: Br J Ophthalmol Date: 2011-01-20 Impact factor: 4.638

6. Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy.

Authors: Mei Zhang; Jiaqi Chen; Lihui Luo; Qiguo Xiao; Mingxia Sun; Zuguo Liu
Journal: Cornea Date: 2005-10 Impact factor: 2.651

7. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

Authors: K Sall; O D Stevenson; T K Mundorf; B L Reis
Journal: Ophthalmology Date: 2000-04 Impact factor: 12.079

Cyclosporine in ocular surface inflammation.

1. Blepharitis: remains a diagnostic enigma. A role for tea tree oil shampoo?

Review 2. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007).

3. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine.

4. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.

5. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis.

6. Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy.

7. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

8. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye.

9. The cornea in Sjogren's syndrome: an in vivo confocal study.

10. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome.

Review 1. Inflammation and dry eye disease-where are we?

Review 2. Preferred practice patterns for photorefractive keratectomy surgery.